pancreatic body and tail cancer
Conditions
Interventions
The laparoscopy is performed in the operating room in the supine position under general anesthesia. A trocar with a balloon with a lumen of 5 mm or 12 mm is inserted from the umbilicus to serve as the
Sponsors
Toyama University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)Patients must be at least 20 years old. (2)Patients with lesions suspected to be invasive pancreatic ductal carcinoma (Pancreatic Cancer Treatment Regulations, 7th Edition) on various imaging examinations (3)Patients with lesions located in the pancreatic tail (4)Patients with ECOG performance status 0-2 (5) Patients with a negative result (CY0) on laparoscopic examination by laparoscopic cytology (6) Patients who require histological diagnosis by EUS-FNA to determine or select a treatment strategy. (7)Patients for whom transgastric EUS-FNA is anticipated.
Exclusion criteria
Exclusion criteria: (1)Patients who have been previously treated for pancreatic cancer (2)Patients who have already undergone laparoscopy and EUS-FNA in the past (3)Patients who are difficult to administer general anesthesia (4) Patients with bleeding tendency (PT INR >1.5 or Plt <50,000 micro L). (5) Patients who cannot discontinue antithrombotic drugs (6) Patients with inability to visualize masses by EUS due to a history of gastrectomy, etc. (7)Patients with blood vessels or other tumors in the puncture route according to various imaging examinations performed prior to enrollment. (8)Patients who are judged to be inappropriate as subjects by the investigator(subinvestigator).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of positive abdominal lavage cytology after EUA-FNA | — |
Countries
Japan
Contacts
Public ContactMina Fukasawa
Toyama University Hospital Department of Surgery and Science
Outcome results
None listed